JP2020536507A5 - - Google Patents

Info

Publication number

JP2020536507A5

JP2020536507A5 JP2020515692A JP2020515692A JP2020536507A5 JP 2020536507 A5 JP2020536507 A5 JP 2020536507A5 JP 2020515692 A JP2020515692 A JP 2020515692A JP 2020515692 A JP2020515692 A JP 2020515692A JP 2020536507 A5 JP2020536507 A5 JP 2020536507A5

Authority

JP

Japan

Prior art keywords

seq

nos

amino acid

acid sequence

antigen

Prior art date

2018-09-18

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims description 127
• 102000025171 antigen binding proteins Human genes 0.000 claims description 106
• 108091000831 antigen binding proteins Proteins 0.000 claims description 106
• 102000003859 Claudin-6 Human genes 0.000 claims description 65
• 108090000229 Claudin-6 Proteins 0.000 claims description 65
• 210000004027 cell Anatomy 0.000 claims description 57
• 150000001413 amino acids Chemical class 0.000 claims description 29
• 238000000034 method Methods 0.000 claims description 24
• 108020001507 fusion proteins Proteins 0.000 claims description 21
• 102000037865 fusion proteins Human genes 0.000 claims description 21
• 206010028980 Neoplasm Diseases 0.000 claims description 20
• 201000011510 cancer Diseases 0.000 claims description 17
• 102000004106 Claudin-3 Human genes 0.000 claims description 15
• 108090000599 Claudin-3 Proteins 0.000 claims description 15
• 108090000601 Claudin-4 Proteins 0.000 claims description 15
• 102000004161 Claudin-4 Human genes 0.000 claims description 15
• 108050007295 Claudin-9 Proteins 0.000 claims description 15
• 102000018157 Claudin-9 Human genes 0.000 claims description 15
• 239000008194 pharmaceutical composition Substances 0.000 claims description 15
• 102000039446 nucleic acids Human genes 0.000 claims description 12
• 108020004707 nucleic acids Proteins 0.000 claims description 12
• 150000007523 nucleic acids Chemical class 0.000 claims description 12
• 239000013598 vector Substances 0.000 claims description 10
• 230000004614 tumor growth Effects 0.000 claims description 9
• 241000699670 Mus sp. Species 0.000 claims description 6
• 238000003556 assay Methods 0.000 claims description 6
• 239000006143 cell culture medium Substances 0.000 claims description 6
• 102000004169 proteins and genes Human genes 0.000 claims description 6
• 108090000623 proteins and genes Proteins 0.000 claims description 6
• 206010005003 Bladder cancer Diseases 0.000 claims description 4
• 206010014733 Endometrial cancer Diseases 0.000 claims description 4
• 206010014759 Endometrial neoplasm Diseases 0.000 claims description 4
• 206010033128 Ovarian cancer Diseases 0.000 claims description 4
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 4
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 4
• 239000000654 additive Substances 0.000 claims description 4
• 230000000996 additive effect Effects 0.000 claims description 4
• 239000003085 diluting agent Substances 0.000 claims description 4
• 239000003937 drug carrier Substances 0.000 claims description 4
• 230000012010 growth Effects 0.000 claims description 4
• 229910052739 hydrogen Inorganic materials 0.000 claims description 4
• 230000005764 inhibitory process Effects 0.000 claims description 4
• 238000004519 manufacturing process Methods 0.000 claims description 4
• 239000000523 sample Substances 0.000 claims description 4
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 4
• 230000006907 apoptotic process Effects 0.000 claims description 3
• 210000004881 tumor cell Anatomy 0.000 claims description 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
• 229920001817 Agar Polymers 0.000 claims description 2
• 239000008272 agar Substances 0.000 claims description 2
• 239000012472 biological sample Substances 0.000 claims description 2
• 201000001441 melanoma Diseases 0.000 claims description 2
• 230000002018 overexpression Effects 0.000 claims description 2
• 230000036039 immunity Effects 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 230000027455 binding Effects 0.000 description 11
• 230000002611 ovarian Effects 0.000 description 7
• 230000003993 interaction Effects 0.000 description 6
• 238000012875 competitive assay Methods 0.000 description 4
• 230000002496 gastric effect Effects 0.000 description 4
• 210000005265 lung cell Anatomy 0.000 description 4
• 230000002401 inhibitory effect Effects 0.000 description 3
• 239000002773 nucleotide Substances 0.000 description 3
• 125000003729 nucleotide group Chemical group 0.000 description 3
• 210000003443 bladder cell Anatomy 0.000 description 2
• 210000005168 endometrial cell Anatomy 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 210000003494 hepatocyte Anatomy 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 102100032306 Aurora kinase B Human genes 0.000 description 1
• 101000798306 Homo sapiens Aurora kinase B Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 230000009137 competitive binding Effects 0.000 description 1
• 230000008094 contradictory effect Effects 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1